Unmodified Versus Leuko-reduced Allogeneic Red Blood Cells Transfusion in Cancer Patients
NCT00180869
Cancer, Neoplasms
Villejuif, France
View Trial DetailsNCT Number: NCT02759965
The primary hypothesis that orthopaedic surgery induces a neuroinflammatory response within 48 hours after elective hip or knee surgery and that there is an association between exaggerated CNS inflammatory response or impaired inflammatory resolution and postoperative cognitive dysfunction within one week and at three months postoperatively.
Looking for future studies?
Notify Me50 year–85 year
Male
Observational
Sahlgrenska University Hospital, Gothenburg, Sweden
Patients at 50-85 years of age undergoing orthopedic surgery will be investigated in the perioperative period to detect signs of neuroinflammation using serial CSF and blood sampling for 48 hours in combination with cognitive testing preoperatively, at 3-7 days and after 3 months.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: Up to 48 hours postoperatively
IL-6 in CSF
Time frame: Before surgery, within 7 days after surgery and 3 month after surgery
A cognitive test battery will be applied
Time frame: Up to 48 hours
Cytokines i peripheral blood
Time frame: Up to 48 hours
CNS specific markers in blood
Time frame: Up to 48 hours postoperatively
CNS specific markers in CSF
Time frame: Up to 48 hours postoperatively
INflammatory Inflammatory markers in CSF
Karolinska University Hospital
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00180869
Cancer, Neoplasms
Villejuif, France
View Trial DetailsNCT06619730
Surgery
Chicago, Illinois, United States
View Trial DetailsNCT06287151
Surgery
Columbus, Ohio, United States
View Trial DetailsNCT06502184
Anxiety Disorders, Behavior
Cologne, Germany
View Trial Details